Healthcare -
Biotechnology - NASDAQ - US
$ 22.04
-0.136 %
$ 3.74 B
Market Cap
-9.97
P/E
IMVT - SHORT-TERM DEBT
Short-term Debt IMVT - Immunovant, Inc.
276 K
LAST VALUE
-50.90%
2 YEAR CAGR
-1.65%
5 YEAR CAGR
0.00%
10 YEAR CAGR